The Daily Punch The Future of Medicine: State of Play
May 13, 2025
Dive into the evolving landscape of medicine where regulations and innovation collide. Discover how technology and the legislative environment impact drug development, with only 10% of new drugs reaching the market. Explore the 'pill penalty' and its implications for medical breakthroughs, as well as how recent reforms aim to enhance pharmaceutical production. The integration of AI is also highlighted as a game-changer for addressing rare diseases. Get ready for a thought-provoking discussion on the future of healthcare!
AI Snips
Chapters
Transcript
Episode notes
Long Risky Drug Approval Process
- It takes about seven to eight years to take a drug from development to market approval.
- Only 10 percent of drugs submitted for approval are ever approved, making it a costly and risky process.
Incentives Needed for Rare Disease Drugs
- Developing drugs for rare diseases is less profitable due to small patient populations.
- The industry seeks incentives, especially for orphan drugs that treat rare diseases.
AI Accelerates Drug Development
- AI significantly speeds up drug development by analyzing large data sets quickly.
- It also improves clinical trials, data analysis, administrative tasks, and doctor-patient interactions.